[Company Contact FOR RELEASE ON NOVEMBER 7, 2011 AT 4:20 p.m. EST (New York) China Biologic Reports Third Quarter 2011 Results TAI'AN, Shandong Province, China, November 7, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported its financial results for] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 7, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of October 6, 2011, is made by and between China Biologic Products, Inc., a Delaware corporation (the “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance] [Company contact Mr. Y. Tristan Kuo China Biologic Announces Changes in Directors BEIJING, October 6, 2011 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced two changes in its board of directors. On October 6, 2011, Dr. Xiangmin Cui resigned from his] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): October 6, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

[Company Contact FOR RELEASE ON AUGUST 9, 2011 AT 4:35 p.m. EDT (New York) China Biologic Products Reports Second Quarter 2011 Results TAI'AN, Shandong Province, China, August 9, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported its results for] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 9, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]